Tag Archives: Cleared

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. Here are a few updates. The Drug Enforcement Administration (DEA) has recommended that brexanolone be placed in schedule IV of… Read More »

First Device for Predicting Risk of Pressure Ulcers FDA Cleared

January 4th, 2019 Editors Critical Care, Medicine, Plastic Surgery, Surgery, Vascular Surgery Pressure ulcers are a common malady for bedridden patients, a situation that clinicians have been struggling to improve significantly. There are devices that sense how long a part of a body has been pressed on for too long, beds that deflate and inflate… Read More »

POPS! one System for Easy Blood Glucose Testing Cleared by FDA

December 7th, 2018 Editors Medicine, Net News, Pediatrics POPS! Diabetes Care, a company based outside of Minneapolis, won FDA clearance for its unusual, but certainly innovative, POPS! one blood glucose monitoring system. The system consists of a device that can (optionally) stick to the back of your smartphone. It is used to take readings, which… Read More »